ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,648.03
      0.30%
      US Tech 100
      19,770.00
      -0.38%
      Dow Jones
      40,782.54
      1.42%
      Brent Oil
      83.395
      -1.12%
      Bitcoin
      63,763.22
      -1.67%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX
      6. Synthetic Biologics Inc (SYN)

      7. Synthetic Biologics Inc (SYN) News

      SYN

      Synthetic Biologics (SYN)

      Synthetic Biologics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:AMEX:SYN
      DateTimeSourceHeadlineSymbolCompany
      09/12/20141:23PMPR Newswire (US)Synthetic Biologics Receives Orphan Drug Designation for SYN-005 Treatment for Whooping Cough (Pertussis)AMEX:SYNSynthetic Biologics Inc
      09/11/20146:58AMPR Newswire (US)Synthetic Biologics to Host Phase II Trimesta™ for Multiple Sclerosis Conference CallAMEX:SYNSynthetic Biologics Inc
      09/10/201412:04PMPR Newswire (US)Synthetic Biologics to Webcast September 16, 2014 Irritable Bowel Syndrome (IBS) Investor DayAMEX:SYNSynthetic Biologics Inc
      09/09/20149:37AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:SYNSynthetic Biologics Inc
      09/08/20146:58AMPR Newswire (US)Synthetic Biologics Highlights SYN-005 Data Presented at the 54th ICAAC from Novel Whooping Cough (Pertussis) ProgramAMEX:SYNSynthetic Biologics Inc
      09/07/20148:58AMPR Newswire (US)Synthetic Biologics Highlights New Data from C. difficile Program Presented at the 54th ICAACAMEX:SYNSynthetic Biologics Inc
      09/03/20146:58AMPR Newswire (US)Synthetic Biologics to Present at the 16th Annual Rodman & Renshaw Global Investment Conference in New York CityAMEX:SYNSynthetic Biologics Inc
      09/02/20147:33AMPR Newswire (US)Synthetic Biologics to Initiate Clinical Trials of SYN-004 in 4Q 2014 to Prevent Potentially Deadly C. difficile InfectionsAMEX:SYNSynthetic Biologics Inc
      08/28/20146:56AMPR Newswire (US)Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004...AMEX:SYNSynthetic Biologics Inc
      08/26/20146:58AMPR Newswire (US)Synthetic Biologics Announces Presentation of Poster for SYN-004 C. difficile Program at IDWeek 2014™AMEX:SYNSynthetic Biologics Inc
      08/19/20146:56AMPR Newswire (US)Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAACAMEX:SYNSynthetic Biologics Inc
      08/14/20142:20PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:SYNSynthetic Biologics Inc
      08/14/201411:14AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:SYNSynthetic Biologics Inc
      08/14/20146:58AMPR Newswire (US)Synthetic Biologics Reports Second Quarter 2014 Financial Results and Operational HighlightsAMEX:SYNSynthetic Biologics Inc
      08/13/20146:56AMPR Newswire (US)Synthetic Biologics to Host Irritable Bowel Syndrome (IBS) Investor DayAMEX:SYNSynthetic Biologics Inc
      08/12/20146:58AMPR Newswire (US)Synthetic Biologics' Academic Collaborator to Present Novel Monoclonal Antibody Combination for Treatment of Whooping Cough (...AMEX:SYNSynthetic Biologics Inc
      08/07/20146:56AMPR Newswire (US)Synthetic Biologics to Report Second Quarter 2014 Financial ResultsAMEX:SYNSynthetic Biologics Inc
      08/05/20146:58AMPR Newswire (US)Synthetic Biologics on Track to Initiate Clinical Program for SYN-004 to Protect Against C. difficileAMEX:SYNSynthetic Biologics Inc
      07/31/20146:57AMPR Newswire (US)Expanded Data on Disability and Cognitive Improvements in Phase II Study of Synthetic Biologics' Trimesta™ in Multiple Scle...AMEX:SYNSynthetic Biologics Inc
      07/29/20141:28PMPR Newswire (US)Synthetic Biologics, Inc. States that Its Policy is Not to Comment on Unusual Market ActivityAMEX:SYNSynthetic Biologics Inc
      07/21/20146:58AMPR Newswire (US)Synthetic Biologics' Academic Collaborator to Present Novel Monoclonal Antibody Combination for Treating Whooping Cough (Pert...AMEX:SYNSynthetic Biologics Inc
      06/30/20146:57AMPR Newswire (US)Synthetic Biologics Forms Clinical Advisory Board to Support Novel C. difficile Preventative ProgramAMEX:SYNSynthetic Biologics Inc
      06/25/20146:57AMPR Newswire (US)Synthetic Biologics Reports that Licensor Cedars-Sinai Finds Eradication of Gut Methane Improves Insulin Sensitivity and Lipi...AMEX:SYNSynthetic Biologics Inc
      06/13/201411:09AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:SYNSynthetic Biologics Inc
      06/10/20143:00AMPR Newswire (US)Synthetic Biologics and Enterome Bioscience Collaborate on Microbiome Research to Support Synthetic Biologics' C. difficile P...AMEX:SYNSynthetic Biologics Inc
      06/10/20143:00AMPR Newswire (US)Synthetic Biologics and Enterome Bioscience Collaborate on Microbiome Research to Support Synthetic Biologics' C. difficile P...AMEX:SYNSynthetic Biologics Inc
      06/10/20143:00AMPR Newswire (US)Synthetic Biologics and Enterome Bioscience Collaborate on Microbiome Research to Support Synthetic Biologics' C. difficile P...AMEX:SYNSynthetic Biologics Inc
      05/27/201410:37AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:SYNSynthetic Biologics Inc
      05/27/20146:11AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:SYNSynthetic Biologics Inc
      05/20/20142:48PMPR Newswire (US)Synthetic Biologics to Present at the 3rd Annual Marcum LLP MicroCap ConferenceAMEX:SYNSynthetic Biologics Inc
       Showing the most relevant articles for your search:AMEX:SYN